CD274 and neoplasm: PD-L1 expression may be a marker of a tumor poised to respond to immune stimulatory effects of chemotherapy or perhaps because PD-L1 may suppress the activity of immune-suppressive immune cells (i.e. Tregs), PD-L1 expression on immune cells could tip the balance towards a more favorable immune microenvironment [24].